GDF15 and metabolic dysfunction-associated steatotic liver disease: In addition, studies on mice with NAFLD have shown that GDF-15 may ameliorate hepatic steatosis and NASH through direct anti-steatotic and anti-inflammatory effects that may be independent of reduction in body weight [207].